Thus, in several in vitro studies, DEX was used to induce sarcopenia in muscle-related research models as it significantly increases the expression of MAFbx/atrogin-1 and MuRF1, key regulators of UPS activity, in C2C12 myotubes [60,61,62]. This evidence concerns the gene FBXO32 and sarcopenia.